Literature DB >> 24990282

Why exercise capacity does not improve after pulmonary valve replacement.

Lauren E Sterrett1, Eric S Ebenroth, Christina Query, Jason Ho, Gregory S Montgomery, Roger A Hurwitz, Fitsum Baye, Marcus S Schamberger.   

Abstract

Optimal timing of pulmonary valve replacement (PVR) for pulmonary regurgitation is a debated topic. It is logical that maximal aerobic capacity (VO2peak) would decline when a PVR is needed, but a diminished VO2peak is not always present before PVR, and previous studies show no improvement in VO2peak after PVR. This study aimed to evaluate changes in resting spirometry from pre- to post-PVR sternotomy, to determine the limiting factors of VO2peak before and after PVR, and to determine whether changes in resting lung function after PVR may explain the lack of improvement in VO2peak after surgery. For 26 patients (age, 19.7 ± 7.8 years) with a history of right ventricular outflow tract revision, the study prospectively evaluated echocardiograms, resting spirometry, and maximal exercise tests before PVR and then an average of 15 months after PVR. Flow volume loops were reviewed by a pulmonologist and categorized as obstructive, restrictive, both obstructive and restrictive, or normal. Exercise tests were interpreted using Eschenbacher's algorithm to determine the primary factors limiting exercise. No change in VO2peak or spirometry after PVR was observed. Before PVR, many patients had abnormal resting lung functions (85 % abnormal), which was unchanged after PVR (86 5 % abnormal). The majority of the patients had a ventilatory limitation to VO2peak before PVR (66.7 %), whereas 28.5 % had a cardiovascular limitation, and 4.8 % had no clear limitation. After PVR, 65.2 % of the patients had a ventilatory limitation, whereas 30.4 % had a cardiovascular limitation, and 4.4 % had no clear limitation to VO2peak. Pulmonary function did not change up to 15 months after surgical PVR. The frequency of pulmonary limitation to VO2peak after PVR did not increase. The effect of pulmonary function on exercise-related symptoms must be considered in this patient population. Improved cardiac hemodynamics are unlikely to improve VO2peak in a primarily pulmonary-limited patient.

Entities:  

Mesh:

Year:  2014        PMID: 24990282     DOI: 10.1007/s00246-014-0942-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  22 in total

1.  Atrial septal defect in adults: cardiopulmonary exercise capacity before and 4 months and 10 years after defect closure.

Authors:  U Helber; R Baumann; H Seboldt; U Reinhard; H M Hoffmeister
Journal:  J Am Coll Cardiol       Date:  1997-05       Impact factor: 24.094

2.  Cardiopulmonary exercise function among patients undergoing transcatheter pulmonary valve implantation in the US Melody valve investigational trial.

Authors:  Anjan S Batra; Doff B McElhinney; Wayne Wang; Richard Zakheim; Robert P Garofano; Curt Daniels; Delphine Yung; Dan M Cooper; Jonathan Rhodes
Journal:  Am Heart J       Date:  2012-02       Impact factor: 4.749

3.  Reduction of QRS duration following pulmonary valve replacement in tetralogy of Fallot: implications for arrhythmia reduction?

Authors:  Elizabeth A Stephenson; Andrew N Redington
Journal:  Eur Heart J       Date:  2005-03-31       Impact factor: 29.983

4.  Pulmonary function thirteen to twenty-six years after repair of tetralogy of Fallot.

Authors:  H Jonsson; T Ivert; R Jonasson; H Wahlgren; A Holmgren; V O Björk
Journal:  J Thorac Cardiovasc Surg       Date:  1994-12       Impact factor: 5.209

5.  Resting lung function in children after repair of tetralogy of Fallot.

Authors:  C Gaultier; M Boule; M Thibert; F Leca
Journal:  Chest       Date:  1986-04       Impact factor: 9.410

6.  Homograft insertion for pulmonary regurgitation after repair of tetralogy of fallot improves cardiorespiratory exercise performance.

Authors:  B Eyskens; T Reybrouck; J Bogaert; S Dymarkowsky; W Daenen; M Dumoulin; M Gewillig
Journal:  Am J Cardiol       Date:  2000-01-15       Impact factor: 2.778

7.  Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease?

Authors:  I Rahman; E Swarska; M Henry; J Stolk; W MacNee
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

8.  Right ventricular outflow tract reconstruction for pulmonary regurgitation after repair of tetralogy of Fallot. Preliminary results.

Authors:  Olivier Ghez; Victor T Tsang; Alessandra Frigiola; Louise Coats; Andrew Taylor; Carin Van Doorn; Philip Bonhoeffer; Marc De Leval
Journal:  Eur J Cardiothorac Surg       Date:  2007-01-30       Impact factor: 4.191

9.  Pathologic lung function in children and adolescents with congenital heart defects.

Authors:  H Lubica
Journal:  Pediatr Cardiol       Date:  1996 Sep-Oct       Impact factor: 1.655

10.  Lung function and pulmonary regurgitation limit exercise capacity in postoperative tetralogy of Fallot.

Authors:  S A Rowe; K G Zahka; T A Manolio; P J Horneffer; L Kidd
Journal:  J Am Coll Cardiol       Date:  1991-02       Impact factor: 24.094

View more
  3 in total

1.  The Effects of Pulmonary Valve Replacement for Severe Pulmonary Regurgitation on Exercise Capacity and Cardiac Function.

Authors:  Jason G Ho; Marcus S Schamberger; Roger A Hurwitz; Tiffanie R Johnson; Lauren E Sterrett; Eric S Ebenroth
Journal:  Pediatr Cardiol       Date:  2015-03-10       Impact factor: 1.655

2.  Speckle-Tracking Echocardiographic Measures of Right Ventricular Function Correlate With Improvement in Exercise Function After Percutaneous Pulmonary Valve Implantation.

Authors:  Shahryar M Chowdhury; Ziyad M Hijazi; John T Fahey; John F Rhodes; Saibal Kar; Raj Makkar; Michael Mullen; Qi-Ling Cao; Girish S Shirali
Journal:  J Am Soc Echocardiogr       Date:  2015-06-24       Impact factor: 5.251

3.  Short-Term Change of Exercise Capacity in Patients with Pulmonary Valve Replacement after Tetralogy of Fallot Repair.

Authors:  Tae Woong Hwang; Sung Ook Kim; Moon Sun Kim; So Ick Jang; Seong Ho Kim; Sang Yun Lee; Eun Young Choi; Su Jin Park; Hye Won Kwon; Hyo Bin Lim
Journal:  Korean Circ J       Date:  2017-03-13       Impact factor: 3.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.